{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:37:02Z","timestamp":1774593422071,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,24]]},"group-title":"Cancer Biology","reference-count":107,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["DP1 AG048917"],"award-info":[{"award-number":["DP1 AG048917"]}]},{"name":"NIH","award":["F32 AG071208-01"],"award-info":[{"award-number":["F32 AG071208-01"]}]},{"name":"NIH","award":["P30 AG031679"],"award-info":[{"award-number":["P30 AG031679"]}]},{"DOI":"10.13039\/100008035","name":"Harvard Stem Cell Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008035","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School"},{"name":"NIH","award":["R01AR083416"],"award-info":[{"award-number":["R01AR083416"]}]},{"name":"NIH","award":["R01AR080110"],"award-info":[{"award-number":["R01AR080110"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Oral squamous cell carcinomas (OSCC) account for \u223c90% of all oral malignancies and have devastating effects on overall health and quality of life. However, little is known about the early initiating events that drive the development of oral leukoplakia-like premalignant lesions (OPLs) and disease progression. Here, we create a mouse model of tobacco-related premalignant OSCC that takes into consideration its primary risk factors, including advancing age and male sex. This model notably recapitulates the age variant patterns of OSCC risk observed in humans, with a higher prevalence of oral premalignant lesions in older mice. In addition, by building a transcriptomic atlas with this system, we reveal genetic signatures associated with oncogenic progression in the tongue and buccal epithelium, and their resident somatic tissue stem cells. We also identify several novel transcriptomic signatures of premalignancy in OSCC, including enhanced immune response and expansion and dysregulation of head and neck tissue stem cells. These findings offer a new framework for investigating physiologically-relevant risk factors and drivers of OSCC and illuminate novel biological pathways underlying its pathology.<\/jats:p>","DOI":"10.64898\/2026.03.20.713236","type":"posted-content","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:40:14Z","timestamp":1774381214000},"source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic atlas of premalignant oral squamous cell carcinoma in an aging mouse model reveals an enhanced immune response and dysregulation of head and neck tissue stem cells"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-1834","authenticated-orcid":false,"given":"Heidi","family":"Kletzien","sequence":"first","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA 02138, USA"},{"name":"Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA 02115, USA"},{"name":"Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, USA"},{"name":"Masonic Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen-Ahn","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA 02138, USA"},{"name":"Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-0225","authenticated-orcid":false,"given":"Siddhartha G.","family":"Jena","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Buenrostro","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA 02138, USA"},{"name":"Masonic Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Wagers","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA 02138, USA"},{"name":"Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA 02115, USA"},{"name":"Joslin Diabetes Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026032622104294000_2026.03.20.713236v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026032622104294000_2026.03.20.713236v1.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2026032622104294000_2026.03.20.713236v1.3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2026032622104294000_2026.03.20.713236v1.4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0427"},{"key":"2026032622104294000_2026.03.20.713236v1.5","unstructured":"Howlader, N. et al. SEER Cancer Statistics Review, 1975-2016. National Cancer Institute (2019)."},{"key":"2026032622104294000_2026.03.20.713236v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.08.008"},{"key":"2026032622104294000_2026.03.20.713236v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1607591"},{"key":"2026032622104294000_2026.03.20.713236v1.8","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2020) (2022)."},{"key":"2026032622104294000_2026.03.20.713236v1.9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","year":"2008","journal-title":"The Lancet"},{"key":"2026032622104294000_2026.03.20.713236v1.10","doi-asserted-by":"crossref","unstructured":"Coletta, R. D. , Yeudall, W. A. & Salo, T. Vol. 5 1505833 (Frontiers Media SA, 2024).","DOI":"10.3389\/froh.2024.1505833"},{"key":"2026032622104294000_2026.03.20.713236v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-023-00249-w"},{"key":"2026032622104294000_2026.03.20.713236v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2008.05.010"},{"key":"2026032622104294000_2026.03.20.713236v1.13","unstructured":"Stelmes, J. et al. (2019)."},{"key":"2026032622104294000_2026.03.20.713236v1.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.0079"},{"key":"2026032622104294000_2026.03.20.713236v1.15","doi-asserted-by":"crossref","unstructured":"Logemann, J. A. , Pauloski, B. R. , Rademaker, A. W. & Colangelo, L. A. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology 11 (1997).","DOI":"10.1002\/(SICI)1097-0347(199709)19:6<535::AID-HED11>3.0.CO;2-4"},{"key":"2026032622104294000_2026.03.20.713236v1.16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40273-014-0169-3","article-title":"The economic burden of head and neck cancer: a systematic literature review","volume":"32","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"2026032622104294000_2026.03.20.713236v1.17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jamaoto.2018.3982","article-title":"Comparison of the financial burden of survivors of head and neck cancer with other cancer survivors","volume":"145","year":"2019","journal-title":"JAMA Otolaryngology\u2013Head & Neck Surgery"},{"key":"2026032622104294000_2026.03.20.713236v1.18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hed.21705","article-title":"Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators","volume":"34","year":"2012","journal-title":"Head & neck"},{"key":"2026032622104294000_2026.03.20.713236v1.19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mas.21570","article-title":"DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans","volume":"39","year":"2020","journal-title":"Mass spectrometry reviews"},{"key":"2026032622104294000_2026.03.20.713236v1.20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/toxics7010016","article-title":"Recent studies on DNA adducts resulting from human exposure to tobacco smoke","volume":"7","year":"2019","journal-title":"Toxics"},{"key":"2026032622104294000_2026.03.20.713236v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1190"},{"key":"2026032622104294000_2026.03.20.713236v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/nature07943"},{"key":"2026032622104294000_2026.03.20.713236v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/nature14129"},{"key":"2026032622104294000_2026.03.20.713236v1.24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6021138"},{"key":"2026032622104294000_2026.03.20.713236v1.25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mrfmmm.2011.06.004","article-title":"O6-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke","volume":"736","year":"2012","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"2026032622104294000_2026.03.20.713236v1.26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","year":"2020","journal-title":"Nature reviews Disease primers"},{"key":"2026032622104294000_2026.03.20.713236v1.27","first-page":"29","article-title":"Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways","volume":"17","year":"2019","journal-title":"Tobacco induced diseases"},{"key":"2026032622104294000_2026.03.20.713236v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2982"},{"key":"2026032622104294000_2026.03.20.713236v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1769-9"},{"key":"2026032622104294000_2026.03.20.713236v1.30","doi-asserted-by":"crossref","unstructured":"Jawa, Y. et al. Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling. Frontiers in Oncology 11 (2021).","DOI":"10.3389\/fonc.2021.676948"},{"key":"2026032622104294000_2026.03.20.713236v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.05.015"},{"key":"2026032622104294000_2026.03.20.713236v1.32","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1038\/cddis.2013.548","article-title":"Clinical update on cancer: molecular oncology of head and neck cancer","volume":"5","year":"2014","journal-title":"Cell death & disease"},{"key":"2026032622104294000_2026.03.20.713236v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2019.12.004"},{"key":"2026032622104294000_2026.03.20.713236v1.34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/hed.23444","article-title":"Designing biomarker studies for head and neck cancer","volume":"36","year":"2014","journal-title":"Head & neck"},{"key":"2026032622104294000_2026.03.20.713236v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2880160506"},{"key":"2026032622104294000_2026.03.20.713236v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.10.013"},{"key":"2026032622104294000_2026.03.20.713236v1.37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12967-025-06258-z","article-title":"Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer","volume":"23","year":"2025","journal-title":"Journal of translational medicine"},{"key":"2026032622104294000_2026.03.20.713236v1.38","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0022034518775736","article-title":"Impact of age on disease progression and microenvironment in oral cancer","volume":"97","year":"2018","journal-title":"Journal of dental research"},{"key":"2026032622104294000_2026.03.20.713236v1.39","first-page":"1","article-title":"Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology","volume":"11","year":"2020","journal-title":"Nature communications"},{"key":"2026032622104294000_2026.03.20.713236v1.40","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.3390\/ijms21218171","article-title":"Single-cell analysis of different stages of oral cancer carcinogenesis in a mouse model","volume":"21","year":"2020","journal-title":"International journal of molecular sciences"},{"key":"2026032622104294000_2026.03.20.713236v1.41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41421-023-00532-4","article-title":"Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma","volume":"9","year":"2023","journal-title":"Cell discovery"},{"key":"2026032622104294000_2026.03.20.713236v1.42","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-016-0106-6"},{"key":"2026032622104294000_2026.03.20.713236v1.43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111733108"},{"key":"2026032622104294000_2026.03.20.713236v1.44","doi-asserted-by":"crossref","unstructured":"Tan, K. Y. , Eminli, S. , Hettmer, S. , Hochedlinger, K. & Wagers, A. J. Efficient generation of iPS cells from skeletal muscle stem cells. PloS one 6 (2011).","DOI":"10.1371\/journal.pone.0026406"},{"key":"2026032622104294000_2026.03.20.713236v1.45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010929108"},{"key":"2026032622104294000_2026.03.20.713236v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/ijos.2013.46"},{"key":"2026032622104294000_2026.03.20.713236v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.09.027"},{"key":"2026032622104294000_2026.03.20.713236v1.48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/diagnostics13061202","article-title":"Mammaglobin-A expression is highly specific for tumors derived from the breast, the female genital tract, and the salivary gland","volume":"13","year":"2023","journal-title":"Diagnostics"},{"key":"2026032622104294000_2026.03.20.713236v1.49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3892\/ol.2024.14660","article-title":"SCGB1A1 as a novel biomarker and promising therapeutic target for the management of HNSCC","volume":"28","year":"2024","journal-title":"Oncology Letters"},{"key":"2026032622104294000_2026.03.20.713236v1.50","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-5-6-691"},{"key":"2026032622104294000_2026.03.20.713236v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2003.11.005"},{"key":"2026032622104294000_2026.03.20.713236v1.52","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2316"},{"key":"2026032622104294000_2026.03.20.713236v1.53","doi-asserted-by":"crossref","first-page":"108112","DOI":"10.1016\/j.pharmthera.2022.108112","article-title":"Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases","volume":"236","year":"2022","journal-title":"Pharmacology & therapeutics"},{"key":"2026032622104294000_2026.03.20.713236v1.54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12920-025-02192-7","article-title":"The prognostic significance and Immunomodulatory role of SCGB3A1 expression in stage I lung adenocarcinoma","volume":"18","year":"2025","journal-title":"BMC Medical Genomics"},{"key":"2026032622104294000_2026.03.20.713236v1.55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lungcan.2010.04.001","article-title":"Secretoglobin 3A2\/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans","volume":"71","year":"2011","journal-title":"Lung Cancer"},{"key":"2026032622104294000_2026.03.20.713236v1.56","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018020966"},{"key":"2026032622104294000_2026.03.20.713236v1.57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37205"},{"key":"2026032622104294000_2026.03.20.713236v1.58","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.18632\/oncotarget.4683","article-title":"p53 directly activates cystatin D\/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"2026032622104294000_2026.03.20.713236v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.02.031"},{"key":"2026032622104294000_2026.03.20.713236v1.60","first-page":"611","article-title":"Expression of submaxillary gland androgen-regulated protein 3A (SMR3A) in adenoid cystic carcinoma of the head and neck","volume":"36","year":"2016","journal-title":"Anticancer Research"},{"key":"2026032622104294000_2026.03.20.713236v1.61","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0496-2"},{"key":"2026032622104294000_2026.03.20.713236v1.62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/or.2022.8374","article-title":"Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy","volume":"48","year":"2022","journal-title":"Oncology Reports"},{"key":"2026032622104294000_2026.03.20.713236v1.63","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00405-012-2201-6","article-title":"Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery","volume":"270","year":"2013","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"key":"2026032622104294000_2026.03.20.713236v1.64","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.3390\/ijms21186853","article-title":"DNA methylome distinguishes head and neck cancer from potentially malignant oral lesions and healthy oral mucosa","volume":"21","year":"2020","journal-title":"International journal of molecular sciences"},{"key":"2026032622104294000_2026.03.20.713236v1.65","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/s41598-020-63148-8","article-title":"Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer","volume":"10","year":"2020","journal-title":"Scientific reports"},{"key":"2026032622104294000_2026.03.20.713236v1.66","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41598-017-06528-x","article-title":"Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells","volume":"7","year":"2017","journal-title":"Scientific reports"},{"key":"2026032622104294000_2026.03.20.713236v1.67","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2494(96)89642-8"},{"key":"2026032622104294000_2026.03.20.713236v1.68","doi-asserted-by":"publisher","DOI":"10.1007\/BF00366126"},{"key":"2026032622104294000_2026.03.20.713236v1.69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717802115"},{"key":"2026032622104294000_2026.03.20.713236v1.70","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41388-023-02912-2","article-title":"Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway","volume":"43","year":"2024","journal-title":"Oncogene"},{"key":"2026032622104294000_2026.03.20.713236v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.05.009"},{"key":"2026032622104294000_2026.03.20.713236v1.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017"},{"key":"2026032622104294000_2026.03.20.713236v1.73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","year":"2024","journal-title":"Signal transduction and targeted therapy"},{"key":"2026032622104294000_2026.03.20.713236v1.74","doi-asserted-by":"crossref","first-page":"692142","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis","volume":"11","year":"2021","journal-title":"Frontiers in oncology"},{"key":"2026032622104294000_2026.03.20.713236v1.75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","year":"2023","journal-title":"Signal transduction and targeted therapy"},{"key":"2026032622104294000_2026.03.20.713236v1.76","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0114-2"},{"key":"2026032622104294000_2026.03.20.713236v1.77","doi-asserted-by":"crossref","first-page":"1343839","DOI":"10.3389\/fonc.2024.1343839","article-title":"4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time-and stage-dependent changes in the tumor immune microenvironment","volume":"14","year":"2024","journal-title":"Frontiers in Oncology"},{"key":"2026032622104294000_2026.03.20.713236v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.10.015"},{"key":"2026032622104294000_2026.03.20.713236v1.79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.mcb.2020.09.004","article-title":"The 4-NQO mouse model: an update on a well-established in vivo model of oral carcinogenesis","volume":"163","year":"2021","journal-title":"Methods in cell biology"},{"key":"2026032622104294000_2026.03.20.713236v1.80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4067\/S0717-95022012000100055","article-title":"4NQO carcinogenesis: A model of oral squamous cell carcinoma","volume":"30","year":"2012","journal-title":"International Journal of Morphology"},{"key":"2026032622104294000_2026.03.20.713236v1.81","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-08-0211"},{"key":"2026032622104294000_2026.03.20.713236v1.82","doi-asserted-by":"crossref","unstructured":"Prostakishina, E. et al. Premalignant lesions of the oral cavity: a narrative review of factors and mechanisms of transformation into cancer. International Journal of Oral and Maxillofacial Surgery (2024).","DOI":"10.1016\/j.ijom.2024.12.006"},{"key":"2026032622104294000_2026.03.20.713236v1.83","doi-asserted-by":"crossref","unstructured":"Meci, A. , Goyal, N. & Goldenberg, D. Malignant Transformation Rate of Oral Premalignant Disorders: A Large Database Analysis. The Laryngoscope (2025).","DOI":"10.1002\/lary.32236"},{"key":"2026032622104294000_2026.03.20.713236v1.84","doi-asserted-by":"crossref","first-page":"840923","DOI":"10.3389\/fimmu.2022.840923","article-title":"Genetic changes driving immunosuppressive microenvironments in oral premalignancy","volume":"13","year":"2022","journal-title":"Frontiers in immunology"},{"key":"2026032622104294000_2026.03.20.713236v1.85","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0133"},{"key":"2026032622104294000_2026.03.20.713236v1.86","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0091"},{"key":"2026032622104294000_2026.03.20.713236v1.87","doi-asserted-by":"crossref","first-page":"100071","DOI":"10.1016\/j.dentre.2023.100071","article-title":"Oral potentially malignant disorders in older adults: A review","volume":"3","year":"2023","journal-title":"Dentistry Review"},{"key":"2026032622104294000_2026.03.20.713236v1.88","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jnci\/djz238","article-title":"Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study","volume":"112","year":"2020","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"2026032622104294000_2026.03.20.713236v1.89","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41416-021-01411-z","article-title":"Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology","volume":"125","year":"2021","journal-title":"British Journal of Cancer"},{"key":"2026032622104294000_2026.03.20.713236v1.90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40246-023-00519-y","article-title":"Total RNA sequencing reveals gene expression and microbial alterations shared by oral pre-malignant lesions and cancer","volume":"17","year":"2023","journal-title":"Human Genomics"},{"key":"2026032622104294000_2026.03.20.713236v1.91","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz813"},{"key":"2026032622104294000_2026.03.20.713236v1.92","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0080-8"},{"key":"2026032622104294000_2026.03.20.713236v1.93","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.gendis.2022.10.001","article-title":"NK2 homeobox gene cluster: Functions and roles in human diseases","volume":"10","year":"2023","journal-title":"Genes & Diseases"},{"key":"2026032622104294000_2026.03.20.713236v1.94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900827106"},{"key":"2026032622104294000_2026.03.20.713236v1.95","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1038\/s41598-024-64162-w","article-title":"Screening of co-expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing and Clinical Research","volume":"14","year":"2024","journal-title":"Scientific Reports"},{"key":"2026032622104294000_2026.03.20.713236v1.96","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324749"},{"key":"2026032622104294000_2026.03.20.713236v1.97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34238-5"},{"key":"2026032622104294000_2026.03.20.713236v1.98","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3495"},{"key":"2026032622104294000_2026.03.20.713236v1.99","doi-asserted-by":"publisher","DOI":"10.1038\/nm1097-1137"},{"key":"2026032622104294000_2026.03.20.713236v1.100","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2009.121"},{"key":"2026032622104294000_2026.03.20.713236v1.101","doi-asserted-by":"publisher","DOI":"10.31557\/apjcp.2020.21.6.1841"},{"key":"2026032622104294000_2026.03.20.713236v1.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2017.01.002"},{"key":"2026032622104294000_2026.03.20.713236v1.103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27676-3"},{"key":"2026032622104294000_2026.03.20.713236v1.104","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23404"},{"key":"2026032622104294000_2026.03.20.713236v1.105","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn0327"},{"key":"2026032622104294000_2026.03.20.713236v1.106","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.066611"},{"key":"2026032622104294000_2026.03.20.713236v1.107","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202403138"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.20.713236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:11:00Z","timestamp":1774588260000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.20.713236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":107,"URL":"https:\/\/doi.org\/10.64898\/2026.03.20.713236","relation":{},"subject":[],"published":{"date-parts":[[2026,3,24]]},"subtype":"preprint"}}